Harri Blåfield
Impact in
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Hematology top 5%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 11
- Rheumatoid Arthritis Research and Therapies 11
- Systemic Lupus Erythematosus Research 4
-
- Autoimmune and Inflammatory Disorders Research 6
- Co-authors
- Hannu Kautiainen (10 shared papers)Marjatta Leirisalo‐Repo (10 shared papers)Markku Korpela (9 shared papers)Pekka Hannonen (8 shared papers)Timo Möttönen (8 shared papers)Kari Puolakka (8 shared papers)Leena Laasonen (5 shared papers)Markku Hakala (5 shared papers)
- Journals
- Scandinavian Journal of Rheumatology (2 papers)Clinical Rheumatology (2 papers)Annals of the Rheumatic Diseases (2 papers)Arthritis Research & Therapy (1 paper)Arthritis & Rheumatism (2 papers)
- Partner nations
- Finland
In The Last Decade
Harri Blåfield
12 papers receiving 640 citations
Peers
Comparison fields: 5 of 61
- Rheumatology 592
- Hematology 243
- Genetics 125
- Pathology and Forensic Medicine 108
- Drug Discovery 1
Countries citing papers authored by Harri Blåfield
This map shows the geographic impact of Harri Blåfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harri Blåfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harri Blåfield more than expected).
Fields of papers citing papers by Harri Blåfield
This network shows the impact of papers produced by Harri Blåfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harri Blåfield. The network helps show where Harri Blåfield may publish in the future.
Co-authors
The 25 scholars most cited alongside Harri Blåfield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 195 | |
| 2 | 2004 | 144 | |
| 3 | Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis. | 2007 | 97 |
| 4 | 2010 | 78 | |
| 5 | 2012 | 69 | |
| 6 | 2006 | 20 | |
| 7 | 2015 | 18 | |
| 8 | 2013 | 13 | |
| 9 | 2009 | 13 | |
| 10 | 2009 | 11 | |
| 11 | Evaluation of the MDHAQ in Finnish patients with RA [corrected]. | 2005 | 8 |
| 12 | Prognosis of 5-year radiographic erosions of the wrist according to early, late, and persistent wrist swelling or tenderness in patients with early rheumatoid arthritis. | 2007 | 6 |
About Harri Blåfield
Harri Blåfield is a scholar working on Rheumatology, Hematology, Pathology and Forensic Medicine, Genetics and Molecular Biology, having authored 12 papers that have together received 672 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (11 papers), Autoimmune and Inflammatory Disorders Research (6 papers), Lymphoma Diagnosis and Treatment (5 papers), Systemic Lupus Erythematosus Research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), HER2/EGFR in Cancer Research (1 paper), Biosimilars and Bioanalytical Methods (1 paper) and Cellular transport and secretion (1 paper). The work is most often cited by research in Rheumatology (592 citations), Hematology (243 citations), Genetics (125 citations), Pathology and Forensic Medicine (108 citations) and Drug Discovery (1 citation). Harri Blåfield has collaborated with scholars based in Finland. Frequent co-authors include Hannu Kautiainen, Marjatta Leirisalo‐Repo, Markku Korpela, Pekka Hannonen, Timo Möttönen, Kari Puolakka, Leena Laasonen, Markku Hakala, Leena Paimela and Kaisa Vuori. Their work appears in journals such as Scandinavian Journal of Rheumatology, Clinical Rheumatology, Annals of the Rheumatic Diseases, Arthritis Research & Therapy and Arthritis & Rheumatism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.